Chemogenetic afferent modulation to understand spinal cord circuit function and plasticity post injury

Information

  • Research Project
  • 10198063
  • ApplicationId
    10198063
  • Core Project Number
    R01NS114007
  • Full Project Number
    5R01NS114007-02
  • Serial Number
    114007
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    9/1/2020 - 4 years ago
  • Project End Date
    8/31/2025 - 25 days from now
  • Program Officer Name
    BAMBRICK, LINDA LOUISE
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/10/2021 - 3 years ago

Chemogenetic afferent modulation to understand spinal cord circuit function and plasticity post injury

PROJECT SUMMARY Spinal cord injury (SCI) causes life-long neurological impairment, and there is currently no effective treatment. The premise of this proposal is recent work demonstrating that afferent stimulation paired with treadmill training can enhance standing, stepping, and volitional control in humans and animal models. Therefore, it is critically important to understand the mechanisms by which afferent stimulation drives motor improvement. Tools that can identify which afferents are necessary and sufficient to enhance recovery, and that can facilitate characterization of the helpful neural plasticity, are urgently needed. Our long-term goal is to develop approaches for selective afferent modulation, and apply them to the dissection of the mechanisms underlying recovery from SCI. The objective of this grant is to identify which sets of afferents are important for recovery and how spinal circuits change to facilitate it. To achieve selective modulation of afferents and enable genetic tracing we will use Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) that can modulate excitability in specific populations of neurons. To accurately quantify improvement, we will use Deep Learning to analyze large kinematic data sets. Our preliminary data shows strong expression of DREADDs in large diameter DRG neurons, that their activation by CNO can excite or inhibit the H-reflex, and that activation of excitatory DREADDs during treadmill training post-SCI improves stepping. Our main hypothesis is that activation of large afferents by the excitatory DREADD (hM3Dq) during treadmill training will enhance recovery, whereas inhibitory DREADDs (hM4Di) will suppress recovery. Four sub- hypotheses will test whether recovery is mediated by increased afferent projection onto 1) motor neurons, or 2) inhibitory interneurons; or by sprouting of 3) reticulospinal and 4) propriospinal circuits. Our Specific Aims are to determine whether selective expression of DREADDs in (Aim 1) all large diameter (proprioceptive and tactile) neurons and (Aim 2) large proprioceptive afferents only can enhance recovery. The rationale for these aims is that afferent stimulation is hypothesized to work through selective excitation of large diameter sensory afferents (LDSA) that both drive motor pools locally and facilitate proprio- and surpraspinal input. To date, it has not been possible to definitively determine which afferents were recruited after electrical stimulation, or to select between afferents of similar diameter. The significance of this work lies in determining whether recovery is mediated exclusively by proprioceptive axons or a combination of proprioceptive and tactile afferents, and uncovering the mechanisms of functional plasticity in the spinal cord.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R01
  • Administering IC
    NS
  • Application Type
    5
  • Direct Cost Amount
    257802
  • Indirect Cost Amount
    137870
  • Total Cost
    395672
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    853
  • Ed Inst. Type
    BIOMED ENGR/COL ENGR/ENGR STA
  • Funding ICs
    NINDS:395672\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    BNVT
  • Study Section Name
    Bioengineering of Neuroscience, Vision and Low Vision Technologies Study Section
  • Organization Name
    TEMPLE UNIV OF THE COMMONWEALTH
  • Organization Department
    ENGINEERING (ALL TYPES)
  • Organization DUNS
    057123192
  • Organization City
    PHILADELPHIA
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    191226003
  • Organization District
    UNITED STATES